Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials - Bernhard, J; Luo, W; Ribi, K (Lancet Oncol, 2015)
et al.